Oxford Vaccine Group launches world’s first Phase I Bundibugyo ebolavirus vaccine trial
The BDBV strain is responsible for the ongoing ebola outbreak in the Democratic Republic of the Congo (DRC), and Uganda
Read the full articleYou might also wanna read
Vaccine trial launched in Oxford in response to deadly outbreak
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Oxford Ebola Vaccine: What to Know About the New Shot Entering Human Trials
Oxford has launched the first human trial of a vaccine targeting the Bundibugyo strain of Ebola, as the death toll in the Democratic Republi
Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to co
ECDC assessment of modelling evidence on Bundibugyo virus spread in DRC and Uganda Ebola outbreak
This assessment presents an overview and critical appraisal of the available modelling evidence to inform the scale and potential spread of
ecdc.europa.eu·25d ago
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 13 (Reuters) - The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accel
Epidemiological data and scripts for the 2026 Bundibugyo Ebola outbreak (BDBV)
Data and scripts for epidemiological analysis of the 2026 Bundibugyo Ebola outbreak - INRB-UMIE/BDBV2026-Data
github.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.